Around 75 medication competitors dependent on synlet quality sets are being assessed for the therapy

Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment

To order this 485+ page report, which features 195+ figures and 200+ tables, please visit

Leave a Reply